M&A Deal Summary

Mydecine Innovations Group Acquires NeuroPharm

On June 10, 2020, Mydecine Innovations Group acquired medical products company NeuroPharm for 6M USD

Acquisition Highlights
  • This is Mydecine Innovations Group’s 1st transaction in the Medical Products sector.
  • This is Mydecine Innovations Group’s largest (disclosed) transaction.
  • This is Mydecine Innovations Group’s 1st transaction in Canada.
  • This is Mydecine Innovations Group’s 1st transaction in British Columbia.

M&A Deal Summary
Date 2020-06-10
Target NeuroPharm
Sector Medical Products
Buyer(s) Mydecine Innovations Group
Deal Type Add-on Acquisition
Deal Value 6M USD

Target

NeuroPharm

Vancouver, British Columbia, Canada
NeuroPharm, Inc. is a healthcare company that develops pharmaceutical and natural health products addressing mental wellness in vulnerable populations such as Veterans and Emergency Medical Services (EMS) personnel. NeuroPharm is based in Vancouver, British Columbia.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Mydecine Innovations Group

Vancouver, British Columbia, Canada
Category Company
Sector Medical Products
DESCRIPTION

Mydecine Innovations Group, Inc. design, manufacture, and distributor of medical products. Mydecine Innovations Group was founded in 2013 and is based in Vancouver, British Columbia.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (British Columbia) 1 of 1
Country (Canada) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal